Ledger.Open graph →
SEC Form D · filed July 9, 2021

Fuse Biotherapeutics, Inc

Offering
$7.1M
Sold
$2.6M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
LOS ANGELES, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Jacob A. Puig · Laredo, TXDirectorYuanheng W. Liang · Los Angeles, CADirectorGerardo M. Sanchez · Laredo, TXExec · DirectorPaul Song · Los Angeles, CAExec · DirectorAshwin Datta · HILLSBORO, ORDirectorTrevor Bachand · HILLSBORO, ORExec · DirectorSteven Howard · Seattle, WAExecJamey A. Steen · Houston, TXExec · DirectorJeffrey Takimoto · Los Angeles, CAExecChristopher Pallotta · New York, NYExecBrian Rabinovich · Los Angeles, CAExec · DirectorYi Fan · Hong Kong, Hong KongExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗